Paige

Paige is an AI company revolutionizing cancer diagnostics through computational pathology. Spun out of Memorial Sloan Kettering Cancer Center, Paige developed the first FDA-authorized clinical AI application in digital pathology. The platform leverages access to over 25 million digitized pathology slides and genomic data across 40+ cancer types from 800+ institutions in 45+ countries, enabling pathologists to detect and subtype cancers with greater speed and accuracy. Paige's Paige Alba platform supports personalized medicine through deep molecular and cellular analysis. The company was acquired by Tempus to further accelerate AI-driven oncology solutions.